Penumbra is a healthcare company focused on therapies. Co. designs, develops, manufactures and markets products and has a portfolio that addresses various medical conditions. Co.'s neuro products include Penumbra System brand of products that provides a form of mechanical thrombectomy used by physicians to revascularize blood vessels that are blocked by clots in the intracranial vasculature. Co.'s vascular products include the Indigo System, which is designed for aspiration mechanical thrombectomy, utilizing the Penumbra System in ischemic stroke. Co.'s vascular products also include the Ruby Coil System, which consists of detachable coils that are designed for peripheral applications. The PEN stock yearly return is shown above.
The yearly return on the PEN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the PEN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|